Ambalal Sarabhai Enterprises Limited (NSE:AMBALALSA)
India · Delayed Price · Currency is INR 31.99
+1.05 (3.39%)
At close: Jul 21, 2026
NSE:AMBALALSA Market Cap
NSE:AMBALALSA has a market cap or net worth of 2.41 billion as of July 22, 2026. Its market cap has decreased by -12.19% in one year.
Market Cap
2.41B
Enterprise Value
2.81B
Revenue
2.03B
Ranking
n/a
PE Ratio
13.55
Stock Price
31.99
ChartMarket Cap Chart
Since May 31, 1999, NSE:AMBALALSA's market cap has increased from 431.71M to 2.41B, an increase of 458.98%. That is a compound annual growth rate of 6.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 2.41B | 10.18% |
| Dec 31, 2025 | 2.19B | -46.66% |
| Dec 31, 2024 | 4.11B | 40.93% |
| Dec 29, 2023 | 2.91B | 41.34% |
| Dec 30, 2022 | 2.06B | -20.06% |
| Dec 31, 2021 | 2.58B | 66.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medico Remedies | 3.18B |
| Everest Organics | 3.13B |
| Trident Lifeline | 3.11B |
| Medicamen Biotech | 3.05B |
| Astonea Labs | 2.92B |
| Ambalal Sarabhai Enterprises | 2.38B |
| Gennex Laboratories | 2.27B |
| Kerala Ayurveda | 2.16B |